Cardiac Biotech Solutions
(OTC) CBSC
Cardiac Biotech Solutions Financials at a Glance
Market Cap
$6.62M
Revenue (TTM)
$104.06K
Net Income (TTM)
$1.84M
EPS (TTM)
$-0.01
P/E Ratio
-3.77
Dividend
$0.00
Beta (Volatility)
-0.02 (Low)
Dividend
$0.00
Beta (Volatility)
-0.02 (Low)
Price
$0.04
Volume
2,000
Open
$0.04
Price
$0.04
Volume
2,000
Open
$0.04
Previous Close
$0.04
Daily Range
$0.04 - $0.04
52-Week Range
$0.02 - $0.08
Dividend
$0.00
Beta (Volatility)
-0.02 (Low)
Price
$0.04
Volume
2,000
Open
$0.04
Previous Close
$0.04
Daily Range
$0.04 - $0.04
52-Week Range
$0.02 - $0.08
CBSC News
CBSC: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cardiac Biotech Solutions
Industry
Pharmaceuticals
Sector
Health CareCEO
Charles Martin
Website
www.cbscientificinc.comHeadquarters
Las Vegas, CA 92029, US
CBSC Financials
Key Financial Metrics (TTM)
Gross Margin
43%
Operating Margin
-14%
Net Income Margin
-18%
Return on Equity
0%
Return on Capital
90%
Return on Assets
-5%
Earnings Yield
-26.53%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$6.62M
Shares Outstanding
165.44M
Volume
2.00K
Short Interest
0.00%
Avg. Volume
20.27K
Financials (TTM)
Gross Profit
$41.40K
Operating Income
$1.33M
EBITDA
$1.69M
Operating Cash Flow
$1.25M
Capital Expenditure
$0.00
Free Cash Flow
$1.25M
Cash & ST Invst.
$50.01K
Total Debt
$263.09K
Cardiac Biotech Solutions Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$40.33K
+261.3%
Gross Profit
$0.00
-100.0%
Gross Margin
0.00%
N/A
Market Cap
$6.62M
N/A
Market Cap/Employee
$1.32M
N/A
Employees
5
N/A
Net Income
$573.68K
-67.8%
EBITDA
$560.34K
-69.9%
Quarterly Fundamentals
Net Cash
$479.12K
-3868.4%
Accounts Receivable
$88.37K
+890.0%
Inventory
$27.89K
+0.0%
Long Term Debt
$0.00
N/A
Short Term Debt
$485.00K
+238.5%
Return on Assets
-4.87%
N/A
Return on Invested Capital
89.67%
N/A
Free Cash Flow
$141.06K
+72.2%
Operating Cash Flow
$141.06K
+72.2%